Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 2/3 trial assessing safety and efficacy of AqubotulinumtoxinA for enhanced skin quality index (SAFESQIN)in the temporary improvement of mild to moderate face and neck lines and skin quality in adults younger than 65 years of age

Next Previous
X
Search
Trial Profile

A phase 2/3 trial assessing safety and efficacy of AqubotulinumtoxinA for enhanced skin quality index (SAFESQIN)in the temporary improvement of mild to moderate face and neck lines and skin quality in adults younger than 65 years of age

Status: Planning
Phase of Trial: Phase II/III

Latest Information Update: 04 May 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Facial wrinkles; Glabellar lines
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 04 May 2023 New trial record
    • 02 May 2023 According to Aquavit media release, the company has filed an Investigational New Drug Application with the FDA for its flagship intradermal injection of botulinum toxin, Dermatox (aqubotulinumtoxinA).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top